Login / Signup

Treatment of latent infection to achieve tuberculosis elimination in low-incidence countries.

Jonathon R CampbellDavid DowdyKevin Schwartzman
Published in: PLoS medicine (2019)
In a Perspective for the Tuberculosis Special Issue, Kevin Schwartzman and colleagues discuss the choices and implications for personal versus public health benefits when pursuing tuberculosis elimination in low-incidence countries.
Keyphrases
  • mycobacterium tuberculosis
  • public health
  • pulmonary tuberculosis
  • hiv aids
  • adverse drug
  • electronic health record